Lv42
540 积分 2021-11-08 加入
Efficacy and safety of biologics and small molecule drugs for patients with moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis
1小时前
待确认
Ranking treatments in the network meta-analysis should consider the certainty of evidence
2小时前
待确认
Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial
1天前
已完结
Upadacitinib as induction and maintenance therapy for moderately to severely active ulcerative colitis: results from three phase 3, multicentre, double-blind, randomised trials
7天前
已完结
Upadacitinib for ulcerative colitis
7天前
已完结
Biomarkers of nivolumab benefit in resectable non-small cell lung cancer
15天前
已完结
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery
1个月前
已完结
Stereotactic body radiotherapy for oligometastases
1个月前
已完结
EP.12D.03 Characterization of HER2Alterations in 23,321 NSCLC Cases and Real-World Therapeutic Pattern in Chinese HER2-Mutant NSCLC the CHAPTER Study
1年前
已关闭
Pyrotinib in HER2-Mutant Advanced Lung Adenocarcinoma After Platinum-Based Chemotherapy: A Multicenter, Open-Label, Single-Arm, Phase II Study
1年前
已完结
皖公网安备34019202002308
